Spiked Conc. (ng∙g−1) |
| 17 β-estradiol | Estrone | 17 α-ethinylestradiol | Estriol |
6 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%)b | 6.48 108.0 0.36 5.60 4.49 | 6.48 108.0 0.27 4.12 3.16 | 6.63 110.5 0.33 5.00 2.11 | 6.09 101.5 0.18 2.90 1.53 |
60 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%) | 62.28 103.8 3.67 5.89 4.26 | 62.00 103.3 5.11 8.24 5.42 | 64.68 107.8 2.65 4.09 7.80 | 61.44 102.4 2.06 3.35 2.40 |
180 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%) | 181.28 100.7 8.26 4.56 3.75 | 179.2 99.6 11.10 6.19 4.29 | 191.80 106.6 5.47 2.85 6.56 | 183.04 101.7 10.13 5.54 1.69 |